[PDF] Drug Discovery for Psychiatric Disorders by Zoran Rankovic, Richard Hargreaves, Matilda Bingham | Perlego
Get access to over 650,000 titles
Start your free trial today and explore our endless library.
Start free trial
Join perlego now to get access to over 650,000 books
Join perlego now to get access to over 650,000 books
Join perlego now to get access to over 650,000 books
Drug Discovery for Psychiatric Disorders
Drug Discovery for Psychiatric Disorders

Drug Discovery for Psychiatric Disorders

Zoran Rankovic, Richard Hargreaves, Matilda Bingham
Start free trial
shareBook
Share book
pages
678 pages
language
English
format
PDF
availableOnMobile
Available on iOS & Android

Drug Discovery for Psychiatric Disorders

Zoran Rankovic, Richard Hargreaves, Matilda Bingham
Book details
Table of contents

About This Book

The discovery and development of effective medicines for the treatment of psychiatric disorders such as schizophrenia and depression has been heralded as one of the great medical achievements of the past century. Indeed, the profound impact of these medicines on our understanding of the pathophysiology underlying these diseases, the treatment of psychiatric patients and even our social perception of mental illnesses cannot be underestimated. However, there is still an urgent medical need for even more effective, safe and well-tolerated treatments. For example, currently available treatments for schizophrenia address mainly the positive symptoms and largely neglect the negative symptoms and cognitive disfunction which greatly impact overall morbidity. Similarly, whilst the current first line antidepressants show significantly improved side effect profiles compared to the first generation therapies, there still up to 40% of patients who are treatment resistant, and even in the patient population which responds well, the onset of action is slow at typically 2-3 weeks. The aim of this book is to provide the first point of call for those involved or just interested in this rapidly expanding and increasingly fragmented field of research and drug discovery. The editors will combine their wide ranging experience and extensive network of contacts with leading scientists and opinion leaders in this field to provide an authoritative reference text covering the evolution, major advances, challenges and future directions in drug discovery and medicinal chemistry for major psychiatric disorders, such as schizophrenia, depression, anxiety, ADHD, bipolar disorder, addiction and autism.

Read More

Information

Publisher
Royal Society of Chemistry
Year
2012
ISBN
9781849734943
Topic
Biological Sciences
Subtopic
Biochemistry
Edition
1

Table of contents